Fenske, R.J.; Weeks, A.M.; Daniels, M.; Nall, R.; Pabich, S.; Brill, A.L.; Peter, D.C.; Punt, M.; Cox, E.D.; Davis, D.B.;
et al. Plasma Prostaglandin E2 Metabolite Levels Predict Type 2 Diabetes Status and One-Year Therapeutic Response Independent of Clinical Markers of Inflammation. Metabolites 2022, 12, 1234.
https://doi.org/10.3390/metabo12121234
AMA Style
Fenske RJ, Weeks AM, Daniels M, Nall R, Pabich S, Brill AL, Peter DC, Punt M, Cox ED, Davis DB,
et al. Plasma Prostaglandin E2 Metabolite Levels Predict Type 2 Diabetes Status and One-Year Therapeutic Response Independent of Clinical Markers of Inflammation. Metabolites. 2022; 12(12):1234.
https://doi.org/10.3390/metabo12121234
Chicago/Turabian Style
Fenske, Rachel J., Alicia M. Weeks, Michael Daniels, Randall Nall, Samantha Pabich, Allison L. Brill, Darby C. Peter, Margaret Punt, Elizabeth D. Cox, Dawn Belt Davis,
and et al. 2022. "Plasma Prostaglandin E2 Metabolite Levels Predict Type 2 Diabetes Status and One-Year Therapeutic Response Independent of Clinical Markers of Inflammation" Metabolites 12, no. 12: 1234.
https://doi.org/10.3390/metabo12121234
APA Style
Fenske, R. J., Weeks, A. M., Daniels, M., Nall, R., Pabich, S., Brill, A. L., Peter, D. C., Punt, M., Cox, E. D., Davis, D. B., & Kimple, M. E.
(2022). Plasma Prostaglandin E2 Metabolite Levels Predict Type 2 Diabetes Status and One-Year Therapeutic Response Independent of Clinical Markers of Inflammation. Metabolites, 12(12), 1234.
https://doi.org/10.3390/metabo12121234